Press Release Archive

February 15th, 2010
Clinical Data Presented at JIM 2010 Provide Further Evidence that the Genous™ Bio-engineered R stent™ Could Be a Treatment of Choice for Patients Not Suitable for Long Term Dual Antiplatelet Therapy
February 11th, 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous™ Bio-engineered R stent™ in China
February 1st, 2010
OrbusNeich’s Genous™ Bio-engineered R stent™ Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
January 23rd, 2010
Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeich’s Genous™ Bio-engineered R stent™ in Challenging Patient Subsets
December 9th, 2009
Al Novak Elected Chairman of the Board of OrbusNeich Medical
December 1st, 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
September 23rd, 2009
Pre-clinical Data Show OrbusNeich’s Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies
September 22nd, 2009
Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich\'s Genous™ Bio-engineered R stent™
September 22nd, 2009
OrbusNeich’s Genous™ Bio-engineered R Stent™ is Safe in a Broad Population of Patients with Primary PCI for STEMI
September 15th, 2009
Data From Multiple Clinical Trials of OrbusNeich’s Genous™ Bio-engineered R stent™ to be Presented at TCT 2009
September 11th, 2009
OrbusNeich’s Genous™ Bio-engineered R stent™ is Feasible in Patients Requiring Undeferrable Non-Cardiac Surgery, International Journal of Cardiology Publication Reports
May 20th, 2009
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich’s Genous™ Bio-engineered R stent™ Compared to Drug-Eluting Stents
April 22nd, 2009
OrbusNeich’s Genous™ Bio-engineered R stent™ Demonstrates Impressive Results in Higher Risk Patients
March 16th, 2009
OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific
November 12th, 2008
12-Month Stent Thrombosis Rate is Lower with OrbusNeich’s Genous™ Bio-engineered R stent™ in e-HEALING Registry than with Drug-Eluting Stents in Other Recent Studies
November 7th, 2008
Interim Analysis of Data from e-HEALING Registry of OrbusNeich’s Genous™ Bio-engineered R stent™ to be Presented at AHA Scientific Sessions 2008
October 14th, 2008
Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich\'s Genous™ Bio-engineered R stent™
October 6th, 2008
Data From Multiple Clinical Trials of OrbusNeich’s Genous™ Bio-engineered R stent™ to be Presented at TCT 2008
July 28th, 2008
OrbusNeich Adds Sapphire™ NC Coronary Dilatation Catheter to Product Line-Up
July 7th, 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich’s Genous™ Bio-engineered R Stent™ Has Better Outcomes When Compared to Drug-Eluting Stents
June 9th, 2008
OrbusNeich Receives CE Mark Approval for Scoreflex™ Coronary Dilatation Catheter
May 28th, 2008
OrbusNeich Receives Approval to Market Genous™ Bio-engineered R stent™ in Taiwan
May 15th, 2008
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich’s Genous™ Bio-engineered R stent™ as Safe Alternative to Drug-Eluting Stents
May 8th, 2008
Data from Randomized Pilot Study, Real-World Use of OrbusNeich’s Genous™ Bio-engineered R stent™ to be Presented in Symposium at EuroPCR 2008
May 1st, 2008
Clinical Impact of OrbusNeich’s Genous™ Bio-engineered R stent™ is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
April 22nd, 2008
Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeich’s Genous™ Bio-engineered R stent™
April 7th, 2008
OrbusNeich Receives CE Mark Approval for Sapphire™ 1.25mm PTCA Dilatation Catheter
March 26th, 2008
Multiple Presentations at ACC.08 Feature OrbusNeich’s Genous™ Bio-engineered R stent™
February 15th, 2008
OrbusNeich’s Genous™ Bio-Engineered R Stent™ is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
November 8th, 2007
5,000 Patients Treated With OrbusNeich’s Genous™ Bio-engineered R Stent™ Now Enrolled in Real-Life Use Global Registry
October 18th, 2007
OrbusNeich’s Genous™ Bio-Engineered R Stent™ is Subject of Sessions on Innovation at TCT 2007
September 3rd, 2007
Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich\'s Genous™ Bio-engineered R Stent™ as Alternative to Drug- Eluting Stents
August 30th, 2007
Dr. Robbert de Winter to Present Pros and Cons of Drug-Eluting Stents and the Benefits of Using an Alternative Pro-Healing Stent to European Cardiologists
July 30th, 2007
OrbusNeich Expands Global Sales and Marketing Team
May 23rd, 2007
Efficacy of OrbusNeich’s Genous™ Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
May 21st, 2007
OrbusNeich Receives CE Mark Approval for Blazer™ Cobalt Chromium Stent, Sapphire™ PTCA Dilatation Catheter, Lumina™ Guiding Catheter
June 23rd, 2006
Long Term Follow Up With Genous™ Stent Confirms Continuing Vascular Healing; Contrary To Delayed Restenosis With Drug Eluting Stents
March 1st, 2006
Healing Stent Nine Month Mace Rate Similar to Drug Eluting Stents
February 2nd, 2006
B. Wayne Johnson Promoted to Orbusneich Chief Operating Officer
November 8th, 2005
Pro-Healing Coronary Stent Demonstrates Impressive Patient Results
September 19th, 2005
OrbusNeich Announces Significant Developments in HEALING Clinical Program with Genous™ Bio-engineered Stent
September 14th, 2005
Judith Jaeger Joins OrbusNeich as Director of Clinical Research
September 5th, 2005
OrbusNeich Receives 2005 Technology Innovation Award for its Pioneering Bio-engineered Stent Technology
August 22nd, 2005
OrbusNeich Receives CE Mark Approval for Genous™ World‘s First Bio-engineered Stent
February 4th, 2005
OrbusNeich Appoints Director of Regulatory Programs
January 26th, 2005
Neich Medical Acquires Orbus Medical Technologies,
Acquisition is the Outcome of a Long, Synergistic Relationship